Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs KREBS BIOCHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA KREBS BIOCHEMICALS SANDU PHARMA/
KREBS BIOCHEMICALS
 
P/E (TTM) x 48.8 -6.3 - View Chart
P/BV x 1.4 - - View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SANDU PHARMA   KREBS BIOCHEMICALS
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
KREBS BIOCHEMICALS
Mar-23
SANDU PHARMA/
KREBS BIOCHEMICALS
5-Yr Chart
Click to enlarge
High Rs86190 45.3%   
Low Rs5051 98.3%   
Sales per share (Unadj.) Rs67.624.2 279.8%  
Earnings per share (Unadj.) Rs1.6-11.5 -13.7%  
Cash flow per share (Unadj.) Rs2.1-8.4 -25.1%  
Dividends per share (Unadj.) Rs0.750-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs40.6-46.1 -88.1%  
Shares outstanding (eoy) m9.6621.56 44.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.05.0 20.2%   
Avg P/E ratio x43.3-10.5 -411.2%  
P/CF ratio (eoy) x32.3-14.3 -225.4%  
Price / Book Value ratio x1.7-2.6 -64.2%  
Dividend payout %47.60-   
Avg Mkt Cap Rs m6582,599 25.3%   
No. of employees `000NANA-   
Total wages/salary Rs m111155 71.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m653521 125.3%  
Other income Rs m36 52.7%   
Total revenues Rs m657528 124.5%   
Gross profit Rs m25-158 -15.8%  
Depreciation Rs m566 7.9%   
Interest Rs m130 2.7%   
Profit before tax Rs m22-247 -9.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m70-   
Profit after tax Rs m15-247 -6.2%  
Gross profit margin %3.8-30.3 -12.6%  
Effective tax rate %31.40-   
Net profit margin %2.3-47.4 -4.9%  
BALANCE SHEET DATA
Current assets Rs m255161 159.0%   
Current liabilities Rs m139491 28.3%   
Net working cap to sales %17.8-63.4 -28.2%  
Current ratio x1.80.3 562.6%  
Inventory Days Days6553 122.9%  
Debtors Days Days26837 727.9%  
Net fixed assets Rs m2861,589 18.0%   
Share capital Rs m97216 44.8%   
"Free" reserves Rs m296-1,210 -24.4%   
Net worth Rs m392-995 -39.5%   
Long term debt Rs m01,732 0.0%   
Total assets Rs m5421,750 31.0%  
Interest coverage x28.7-7.3 -392.9%   
Debt to equity ratio x0-1.7 -0.0%  
Sales to assets ratio x1.20.3 404.9%   
Return on assets %3.0-12.4 -23.8%  
Return on equity %3.924.8 15.6%  
Return on capital %5.9-29.4 -19.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m05 0.0%   
Net fx Rs m0-5 -0.0%   
CASH FLOW
From Operations Rs m2-247 -0.9%  
From Investments Rs m5-126 -4.2%  
From Financial Activity Rs m6373 1.6%  
Net Cashflow Rs m130 -8,913.3%  

Share Holding

Indian Promoters % 42.9 72.7 59.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.5 2.0%  
FIIs % 0.0 0.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 27.3 209.5%  
Shareholders   10,021 8,990 111.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs KREBS BIOCHEMICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs KREBS BIOCHEMICALS Share Price Performance

Period SANDU PHARMA KREBS BIOCHEMICALS S&P BSE HEALTHCARE
1-Day -0.45% -4.39% 1.18%
1-Month -15.08% -15.61% -0.75%
1-Year 9.73% 16.38% 61.82%
3-Year CAGR 19.30% -12.15% 18.16%
5-Year CAGR 21.14% -11.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the KREBS BIOCHEMICALS share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of KREBS BIOCHEMICALS the stake stands at 72.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of KREBS BIOCHEMICALS.

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

KREBS BIOCHEMICALS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of KREBS BIOCHEMICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.